Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06D ANTI-DEMENTIA DRUGS
N06DA Anticholinesterases
N06DA04 Galantamine
D02173 Galantamine hydrobromide (JAN/USP) <JP/US>
USP drug classification [BR:br08302]
Antidementia Agents
Cholinesterase Inhibitors
Galantamine
D02173 Galantamine hydrobromide (JAN/USP)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
119 Miscellaneous
1190 Miscellaneous
D02173 Galantamine hydrobromide (JAN/USP)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01595 Cholinesterase inhibitor
DG01593 Acetylcholinesterase inhibitor
DG00985 Galantamine
D02173 Galantamine hydrobromide
DG01968 Antidementia agent
DG00985 Galantamine
D02173 Galantamine hydrobromide
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG00985 Galantamine
D02173 Galantamine hydrobromide
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00985 Galantamine
D02173 Galantamine hydrobromide
Drug classes [BR:br08332]
Neuropsychiatric agent
DG01968 Antidementia agent
D02173 Galantamine hydrobromide
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Carboxylic-ester hydrolases
ACHE
D02173 Galantamine hydrobromide (JAN/USP) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02173
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02173
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02173
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02173
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D02173
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01595 Cholinesterase inhibitor
DG01593 Acetylcholinesterase inhibitor
DG00985 Galantamine
DG01968 Antidementia agent
DG00985 Galantamine
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG00985 Galantamine
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00985 Galantamine